MedPath

Effectiveness and Safety of Fast Enteral Feeding in Preterm Infants Between 1000 and 2000 Grams of Birth Weight

Not Applicable
Completed
Conditions
Feeding Behavior
Interventions
Other: Fast milk advancement
Other: Traditional milk advancement
Registration Number
NCT02998489
Lead Sponsor
Hospital Universitario San Ignacio
Brief Summary

This is a randomized controlled trial with infants less than 34 weeks and between 1000 and 2000 grams at birth, that seeks to establish the safety and effectiveness of fast enteral advancement (milk 30-40 cc/kg/d) compared with traditional advancement (milk 20 cc/kg/d)

Detailed Description

Progression of enteral feeding in preterm infants is still controversial. The neonatologist needs to provide adequate caloric intake avoiding the risk of food intolerance and necrotizing enterocolitis.

Objective: To establish the safety and effectiveness of fast enteral advancement compared with traditional advancement.

Design: A randomized controlled clinical trial with infants less than 34 weeks and between 1000 and 2000 grams at birth conducted at Hospital Universitario San Ignacio in Bogotá, Colombia.

Methods: 30 cc versus 20 cc / kg / day advancing in infants between 1000 and 1499g and 40cc versus 20 cc / kg / day advancing in infants between 1500 and 1999g.

Outcomes: days to reach full enteral nutrition, days of parenteral nutrition (PN) and/or intravenous fluids (IVF), days to regain birth weight, episodes of food intolerance, anthropometric measurements and weight gain at 40 weeks; rate of late onset sepsis, hypoglycemia, hyperbilirubinemia, necrotizing enterocolitis (NEC) and mortality. Data will be analyzed with Student t test or Mann-Whitney U-test and Pearson Chi-square or Fisher test. Multiple linear regression will be performed.

Ethics: This Protocol was approved by the Ethics and Research Committee of Pontificia Universidad Javeriana and San Ignacio Hospital. Informed consent will be requested to parents.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
36
Inclusion Criteria
  • Infants less than 34 weeks of gestational age.
  • Weight at birth between 1000 and 2000 grams.
  • Infants hospitalized in the newborn unit at Hospital Universitario San Ignacio in Bogotá, Colombia.
Exclusion Criteria
  • Perinatal Asphyxia
  • Intrauterine Growth Restriction
  • Diagnosis of Congenital Hearth Disease
  • Severe Hypoxemia
  • Major Congenital Malformations
  • Metabolic Disease
  • Intolerance to initiate oral feeding at the eligibility
  • Patent Ductus with hemodynamic instability
  • Early Onset Sepsis with hemodynamic instability
  • Refusal of parents to participate in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Fast milk advancementFast milk advancement30-40 cc/kg/d of human milk or formula milk administered by orogastric tube or by suction
Traditional milk advancementTraditional milk advancement20 cc/kg/d of human milk or formula milk administered by orogastric tube or by suction
Primary Outcome Measures
NameTimeMethod
days of intravenous fluidsnumber of days of intravenous fluids from birth until suspension of them or date of death from any cause assessed up to 12 weeks

number of days with intravenous fluids included parenteral nutrition and dextrose with electrolytes

days to reach full enteral nutritionnumber of days from date of randomization until the day that the baby reach full enteral nutrition or date of death from any cause assessed up to 12 weeks

number of days employed to reach full enteral nutrition with breast milk, formula milk or breast milk plus formula milk.

Secondary Outcome Measures
NameTimeMethod
episodes of food intolerancenumber of episodes of food intolerance per day from date of randomization until hospital discharge or date of death from any cause assessed up to 12 weeks

number of episodes of food intolerance per day during hospitalization

weight at 40 weeksweight at 40 weeks of post menstrual age

weight in grams at 40 weeks of post menstrual age

rate of hyperbilirubinemiafrom date of randomization until hospital discharge or date of death from any cause assessed up to 12 weeks

number of patients who had hyperbilirubinemia and were treated with phototherapy during hospitalization

rate of hypoglycemiafrom date of randomization until hospital discharge or date of death from any cause assessed up to 12 weeks

number of patients who had hypoglycemia during hospitalization

length at 40 weekslength at 40 weeks of post menstrual age

length in centimeters at 40 weeks of post menstrual age

head circumference at 40 weekshead circumference at 40 weeks of post menstrual age

head circumference in centimeters at 40 weeks of post menstrual age

rate of necrotizing enterocolitisthrough study completion(from date of randomization until 40 weeks of post menstrual age)

rate of necrotizing enterocolitis through study completion

rate of mortalitythrough study completion(from date of randomization until 40 weeks of post menstrual age)

number of patients who died during the study's follow up

rate of late onset sepsisfrom date of randomization until hospital discharge or date of death from any cause assessed up to 12 weeks

number of patients who had late onset sepsis during hospitalization

days to regain birth weightnumber of days from birth, employed to regain birth weight or date of death from any cause assessed up to 12 weeks

number of days employed to regain birth weight

weight gain per day at 40 weeks of post menstrual ageweight gain in grams per day from birth until 40 weeks of post menstrual age

weight gain in gr./d from birth until 40 weeks of post menstrual age

© Copyright 2025. All Rights Reserved by MedPath